Oxidized low density lipoproteins alter macrophage lipid uptake, apoptosis, viability and nitric oxide synthesis

Journal of Nutrition

Volumn 126, Issue 4 SUPPL., 1996, Pages

  Yang, Xiaochun ^b   Galeano, Narmer F ^b   Szabolcs, Matthias ^b   Sciacca, Robert R ^b   Cannon, Paul J ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b NONE

Author keywords

atherosclerosis; macrophages; nitric oxide; nitric oxide synthase; oxidized low density lipoproteins

Indexed keywords

GAMMA INTERFERON; LIPOPOLYSACCHARIDE; LOW DENSITY LIPOPROTEIN; MESSENGER RNA; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; OXIDIZED LOW DENSITY LIPOPROTEIN;

ANIMAL CELL; APOPTOSIS; ATHEROGENESIS; ATHEROSCLEROSIS; BLOOD VESSEL TONE; CELL INTERACTION; CELL VIABILITY; CONFERENCE PAPER; CONTROLLED STUDY; ENDOTHELIUM CELL; LIPID OXIDATION; LIPID TRANSPORT; MACROPHAGE; MOUSE; NONHUMAN; VASCULAR ENDOTHELIUM;

EID: 0029991376     PISSN: 00223166     EISSN: None     Source Type: Journal    
DOI: 10.1093/jn/126.suppl_4.1072s     Document Type: Conference Paper

References (24)

1. Albina, J. E., Cui, S., Mateo, R. B. & Reichner, J. S. (1993) Nitric oxide mediated apoptosis in murine peritoneal macrophages. J. Immunol. 150: 5080-5085.
2. Alexander, R. W. (1995) Hypertension and the pathogenesis of atherosclerosis, oxidative stress and the mediation of arterial inflammatory response: a new perspective. Hypertension 25: 155-161.
3. Berliner, J. A. & Haberland, M. A. (1993) Role of oxidized low density lipoprotein in atherogenesis. Curr. Opin. Lipidol. 4: 373-381.
4. Cathcard, M. D., Morel, D. W. & Chisolm, G. M. III (1985) Monocytes and neutrophils oxidize low density lipoproteins making it cytotoxic. J. Leukoc. Biol. 38: 341-350.
5. Cayatte, A. J., Palacino, J. J., Horten, K. & Cohen, R. A. (1994) Chronic inhibition of nitric oxide production accelerates neointima formation and impairs endothelial function in hypercholesterolemic rabbits. Arterioscler. Thromb. 14: 753-759.
6. Cooke, J. P., Singer, A. H., Tsao, P., Zera, P., Rowan, R. A. & Billingham, M. E. (1992) Antiatherogenic effects of L-arginine in the hypercholesterolemic rabbit. J. Clin. Invest. 90: 1168-1172.
7. Henning, B. & Chow, C. K. (1988) Lipidperoxidation and endothelial cell injury: implications in atherosclerosis. Free Radic. Biol. Med. 4: 99-106.
8. Ignarro, L. J. (1990) Biosynthesis and metabolism of endothelium-derived nitric oxide. Ann. Rev. Toxicol. 30: 535-560.
9. Kosugi, J. P., Cheng, J. & Gospodarowicz, D. (1980) Effect of high and low density lipoproteins on proliferation of cultured vascular endothelial cells. J. Cell Physiol. 130: 311-320.
10. Kume, N., Cybulsky, M. I. & Ginbrone, M. A., Jr. (1992) Lysophosphatidylcholine, a component of atherogenic lipoproteins, induces mononuclear leukocyte adhesion molecules in cultured human and rabbit arterial endothelial cells. J. Clin. Invest. 1138-1144.
11. Kygiyama, K., Kerns, S. A., Morrisett, J. D., Roberts, R. & Henry, P. D. (1990) Impairment of endothelium-dependent arterial relaxation by lysolecithin in modified low-density lipoproteins. Nature 344: 160-162.
12. Moncada, S. & Higgs, A. (1993) The L-arginine:nitric oxide pathway. N. Engl. J. Med. 329: 2002-2012.
13. Munro, J. M. & Cotran, R. S. (1988) The pathogenesis of atherosclerosis: atherogenesis and inflammation. Lab. Invest. 58: 249-261.
14. Nathan, C. (1992) Nitric oxide as a secretory product of mammalian cells. FASEB J. 6: 3051-3064.
15. Pinsky, D. J., Cai, B., Yang, X., Rodriguez, C., Sciacca, R. R. & Cannon, P. J. (1995) The lethal effects of cytokine-induced nitric oxide on cardiac myocytes are blocked by nitric oxide synthase antagonism or transforming growth factor β. J. Clin Invest. 95: 677-685.
16. Quinn, M. T., Parthasarathy, S. & Steinberg, D. (1988) Lysophosphatidylcholine: a chemotactic factor for human monocytes and its potential role in atherogenesis. Proc. Natl. Acad. Sci. U.S.A. 85: 2805-2809.
17. Ross, R. (1986) The pathogenesis of atherosclerosis: an update. N Engl. J. Med. 324: 488-500.
18. Steinberg, D., Parthasarathy, S., Carew, T. E., Khoo, J. D. & Witztum, J. L (1989) Beyond cholesterol: modifications of low density lipoprotein that increase its atherogenicity. N. Engl. J. Med. 320: 915-924.
19. Wilcox, J. M., Subramanian, R. R., Ross, C. E., Tracey, W. R., Pollock, J. S., Harrison, D. G. & Marsden, P. A. (1994) Expression of multiple nitric oxide synthase isoforms in human aortic fatty streaks and advanced atherosclerotic plaque. Circulation 90: 1-298.
20. Witztum, J. L. & Steinberg, G. (1991) Role of oxidized low density lipoprotein in atherogenesis. J. Clin. Invest. 88: 1785-1792.
21. Yang, X., Cai, B., Sciacca, R. R. & Cannon, P. J. (1994a) Inhibition of inducible nitric oxide synthase in macrophages by oxidized low density lipoproteins. Circ. Res. 74: 318-328.
22. Yang, X., Chowdhury, N., Cai, B., Brett, J., Marboe, C., Sciacca, R. R., Michler, R. E. & Cannon, P. J. (1994b) Induction of myocardial nitric oxide synthase by cardiac allograft rejection. J. Clin. Invest. 94: 714-721.
23. Yla-Herttuala, S., Palinski, W., Rosenfeld, M. E., Parthasarathy, S., Carew, T. E., Butler, S., Witztum, J. L. & Steinberg, D. (1989) Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. J. Clin. Invest. 84: 1086-1095.
24. Yokoyama, M., Hirata, K., Miyake, R., Adkita, H. & Fukuzaki, Y. (1990) Lysophosphatidylcholine: essential role in the inhibition of endothelium-dependent vasorelaxation by oxidized low density lipoprotein. Biochem. Biophys. Res. Commun. 168: 301-308.